Experience

Metafold 3D

• Canada
• Software Development
• 1 - 100 Employee

• Advisor

  • Jan 2023 - Present

  Metafold is the leading developer of Design for Additive Manufacturing (DfAM) cloud-based software, advancing the mass adoption of 3D printing with sustainability at the forefront of its mission. Metafold's platform offers large-scale manufacturers the world's fastest geometric engine, huge lattice library, and unmatched direct-to-print capabilities helping teams to imagine, design, and produce 3D parts faster. Metafold's platform is available for free for single users or paid subscriptions for teams and enterprises. For more information, visit https://www.metafold3d.com. Metafold is backed by Differential Ventures, Active Impact Investments, Jetstream and Standup Ventures. https://finance.yahoo.com/news/metafold-secures-1-78m-advance-130000821.html Show less



Sixth Street

• United States
• Financial Services
• 400 - 500 Employee

• Principal, Healthcare & Life Sciences

  • Jan 2021 - Present

  Founded in 2009, Sixth Street is a global investment firm with over $60 billion in assets under management and committed capital. We use our long-term flexible capital, data-enabled capabilities, and "One Team" cultural philosophy to develop themes and offer solutions for companies across all stages of growth. The Sixth Street Healthcare and Life Sciences team provides strategic capital and forms long-term partnerships with companies creating new technologies to address pressing healthcare challenges and improve patient care. Relying on the expertise of our team and our network of senior advisors, we make investments tailored to healthcare and pharma business timelines, whether to develop or launch new medicines, make asset acquisitions, or fund strategic projects. We take a thematic approach to investing across the sector with a particular focus on therapeutics (pharma and biotech), pharma services (CROs, CDMOs and life science tools) and healthcare data. Select Sixth Street Healthcare and Life Sciences investments include Biohaven Pharmaceuticals, Caris Life Sciences, Datavant, Mammoth Biosciences.sixthstreet.com/healthcare/ Show less

• Vice President, Healthcare & Life Sciences

  • Feb 2019 - Jan 2021



DRI Capital

• Canada
• Investment Management
• 1 - 100 Employee

• Director

  • Sep 2013 - Jul 2016

  Worked with a cross-functional team to source and execute deals at an international health care private equity fund with $3 B in assets under management Worked with a cross-functional team to source and execute deals at an international health care private equity fund with $3 B in assets under management



ZS Associates

• Pakistan
• Construction
• 1 - 100 Employee

• Associate

  • Nov 2011 - Sep 2013

  Advised biotechnology and pharmaceutical clients on sales and marketing strategy (Clients based in Switzerland, US, Canada) Projects included drug sales forecasting, product launch strategy, drug pipeline portfolio optimization, post-merger commercial integration Advised biotechnology and pharmaceutical clients on sales and marketing strategy (Clients based in Switzerland, US, Canada) Projects included drug sales forecasting, product launch strategy, drug pipeline portfolio optimization, post-merger commercial integration



LaunchCapital LLC

• United States

• Summer Associate

  • May 2011 - Aug 2011

  Conducted commercial and scientific due diligence on early-stage startups Focused on medical device, therapeutic, diagnostic and mobile health startups Conducted commercial and scientific due diligence on early-stage startups Focused on medical device, therapeutic, diagnostic and mobile health startups



Ontario Genomics Institute

• Analyst

  • May 2008 - Aug 2010

  Conducted commercial and scientific due diligence on early-stage life science technologies Investments included genomics and proteomics projects Conducted commercial and scientific due diligence on early-stage life science technologies Investments included genomics and proteomics projects